GlassScriptPhysician profile
Paul A Perry
NPI 1790948677
$7,864.90
in general payments reported to CMS, 2019-2025
11 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,044 · 2020: $1,970 · 2021: $495 · 2022: $1,442 · 2023: $492 · 2024: $202 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,135.89 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Artivion, INC. | $2,794.95 | 2019-2022 | |
| Atricure, INC. | $581.24 | 2020-2022 | |
| Abbott Laboratories | $511.08 | 2019-2024 | Mitraclip, Amplatzer Talisman |
| Abiomed | $338.26 | 2019-2025 | Impella |
| Medtronic, INC. | $191.29 | 2021-2023 | Simulus, Tri-Ad |
| Angiodynamics, INC. | $145.20 | 2019 | |
| Asahi Intecc USA, INC. | $119.97 | 2020 | |
| Elutia, INC. | $20.40 | 2019 | |
| Medtronic Vascular, INC. | $14.61 | 2020 | |
| Getinge USA Sales, LLC | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.